Register entryShortage reported
- Registered sites
- 1
- Active NDC listings
- 31
- Labeller names
- 3
- Live patents
- 0
- Shortage listings
- 7
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Sunrise Pharmaceutical Inc | 665 East Lincoln Avenue, Rahway, New Jersey (NJ) 07065, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3004813394168522378 |
Alert
Drug shortage listings
7| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 11534-196-01) | Current | Available | 12 Oct 20221 Oct 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 11534-192-01) | Current | Available | 12 Oct 20221 Oct 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 11534-190-01) | Current | Available | 12 Oct 20221 Oct 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 11534-193-01) | Current | Available | 12 Oct 20221 Oct 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 11534-194-01) | Current | Available | 12 Oct 20221 Oct 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 11534-195-01) | Current | Available | 12 Oct 20221 Oct 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 11534-191-01) | Current | Available | 12 Oct 20221 Oct 2026 |
Catalogue
Drug listings by form and route
3131 active NDC listings: 30 human prescription drug, 1 human otc drug. By marketing category: ANDA 31.
| Dosage form | NDCs |
|---|---|
| tablet | 18 |
| capsule | 5 |
| tablet, delayed release | 3 |
| tablet, film coated | 3 |
| powder, for solution | 1 |
| powder, for suspension | 1 |
| Route | NDCs |
|---|---|
| oral | 31 |
| rectal | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| sunrise pharmaceutical, inc. | 15 |
| sunrise pharmaceutical, inc. | 11 |
| sunrise pharmaceutical, inc | 5 |
Catalogue
Marketed products
31| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| BENZTROPINE MESYLATE | benztropine mesylate | tablet, oral | 11534-167ANDA |
| BENZTROPINE MESYLATE | benztropine mesylate | tablet, oral | 11534-168ANDA |
| BENZTROPINE MESYLATE | benztropine mesylate | tablet, oral | 11534-169ANDA |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | butalbital, acetaminophen and caffeine | capsule, oral | 11534-187ANDA |
| Chlordiazepoxide Hydrochloride and Clidinium Bromide | Chlordiazepoxide Hydrochloride and Clidinium Bromide | capsule, oral | 11534-197ANDA |
| DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE | dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate | tablet, oral | 11534-190ANDA |
| DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE | dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate | tablet, oral | 11534-191ANDA |
| DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE | dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate | tablet, oral | 11534-192ANDA |
| DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE | dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate | tablet, oral | 11534-193ANDA |
| DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE | dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate | tablet, oral | 11534-194ANDA |
| DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE | dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate | tablet, oral | 11534-195ANDA |
| DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE | dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate | tablet, oral | 11534-196ANDA |
| DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | tablet, oral | 11534-188ANDA |
| DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | tablet, oral | 11534-189ANDA |
| DIAZEPAM | diazepam | tablet, oral | 11534-199ANDA |
| DIAZEPAM | diazepam | tablet, oral | 11534-202ANDA |
| DIAZEPAM | diazepam | tablet, oral | 11534-203ANDA |
| FOLIC ACID | folic acid | tablet, oral | 11534-165ANDA |
| HYDROXYZINE HYDROCHLORIDE | hydroxyzine hydrochloride | tablet, film coated, oral | 11534-204ANDA |
| HYDROXYZINE HYDROCHLORIDE | hydroxyzine hydrochloride | tablet, film coated, oral | 11534-205ANDA |
| HYDROXYZINE HYDROCHLORIDE | hydroxyzine hydrochloride | tablet, film coated, oral | 11534-206ANDA |
| Naproxen | Naproxen | tablet, delayed release, oral | 11534-211ANDA |
| Naproxen | Naproxen | tablet, delayed release, oral | 11534-212ANDA |
| POLYETHYLENE GLYCOL 3350 NF | polyethylene glycol 3350 | powder, for solution, oral | 11534-180ANDA |
| Phentermine Hydrochloride | phentermine hydrochloride | capsule, oral | 11534-157ANDA |
| Phentermine Hydrochloride | phentermine hydrochloride | capsule, oral | 11534-176ANDA |
| Phentermine hydrochloride | phentermine hydrochloride | capsule, oral | 11534-159ANDA |
| Phentermine hydrochloride | phentermine hydrochloride | tablet, oral | 11534-160ANDA |
| SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | powder, for suspension, oral, rectal | 11534-166ANDA |
| Sulfasalazine | Sulfasalazine | tablet, oral | 11534-200ANDA |
| Sulfasalazine | Sulfasalazine | tablet, delayed release, oral | 11534-201ANDA |
Neighbours
Registered in the same town
1- Waylis TherapeuticsRahway, NJ
Compare
Comparable companies in United States
- Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Greer Laboratories, Inc.1 site · 1,328 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
- HF Acquisition Co LLC1 site · 363 NDC
- ANI Pharmaceuticals, Inc.1 site · 299 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Newton Laboratories, Inc.1 site · 271 NDC
Enquiry
Common questions
- Is Sunrise Pharmaceutical Inc FDA approved?
- Sunrise Pharmaceutical Inc holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Sunrise Pharmaceutical Inc's drugs manufactured?
- The FDA register lists Rahway, NJ. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
- What drugs does Sunrise Pharmaceutical Inc make?
- 31 products are listed under Sunrise Pharmaceutical Inc in the openFDA NDC Directory, most often as tablet; capsule; tablet, delayed release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
- Are any Sunrise Pharmaceutical Inc products in shortage?
- 7 presentations are currently listed in the FDA drug shortage database under Sunrise Pharmaceutical Inc, covering Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.